Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population.
BACKGROUND
Health care utilization and costs among US veterans with chronic obstructive pulmonary disease (COPD) were compared with those in veterans without COPD.


METHODS
A cohort of veterans with COPD was matched for age, sex, race, and index fiscal year to a cohort of veterans without COPD (controls) using data from the Veterans Integrated Service Network (VISN) 16 from 10/1/1997 to 9/30/2004. Annual total and respiratory-related health care service utilization, costs of care, comorbidities, and respiratory medication use at the time of diagnosis were assessed.


RESULTS
A total of 59,906 patients with COPD were identified for a 7-year period prevalence of 8.2%, or 82 per 1000 population. Patients with COPD compared with controls had significantly higher all-cause and respiratory-related inpatient and outpatient health care utilization for every parameter examined including mean numbers of physician encounters, other outpatient encounters, emergency room visits, acute inpatient discharges, total bed days of care, and percentage of patients with any emergency room visits or any acute inpatient discharge. Patients with COPD had statistically significantly higher mean outpatient, inpatient, pharmacy, and total costs than the control group. The mean Charlson comorbidity index in patients with COPD was 1 point higher than in controls (2.85 versus 1.84, P < 0.001). 60% of COPD patients were prescribed medications recommended in treatment guidelines at diagnosis.


CONCLUSIONS
Veterans with COPD compared with those without COPD suffer a tremendous disease burden manifested by higher rates of all-cause and respiratory-related health care utilization and costs and a high prevalence of comorbidities. Furthermore, COPD patients do not receive appropriate treatment for their disease on diagnosis.
Sharafkhaneh
Amir
A
Baylor College of Medicine, Houston, TX, USA. sharafkhaneh.amir@va.gov <sharafkhaneh.amir@va.gov>
Petersen
Nancy J
NJ
Yu
Hong-Jen
HJ
Dalal
Anand A
AA
Johnson
Michael L
ML
Hanania
Nicola A
NA
D000328:Adult; D000368:Aged; D015897:Comorbidity; D017281:Cost of Illness; D003695:Delivery of Health Care / Q000706:statistics & numerical data*; D004358:Drug Therapy / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D019370:Observation; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy / Q000191:economics*; D015272:Pulmonary Medicine; D012189:Retrospective Studies; D014481:United States; D014493:United States Department of Veterans Affairs
Respirology. 2008 Sep;13(5):689-94
18513247
Chest. 2007 Dec;132(6):1748-55
17890477
Prim Care Companion J Clin Psychiatry. 2006;8(2):71-6
16862230
Clin Ther. 2007 Jun;29(6):1203-13
17692734
Am J Manag Care. 2004 Dec;10(12):909-16
15617366
Lung. 2008 Sep-Oct;186(5):307-12
18463921
Natl Vital Stat Rep. 2006 Apr 19;54(13):1-120
16689256
Pharmacoeconomics. 2001;19(6):623-42
11456211
BMC Public Health. 2007 Oct 12;7:290
17935623
COPD. 2005 Mar;2(1):35-41
17136959
Respir Med. 2007 Aug;101(8):1753-60
17448651
Eur J Health Econ. 2009 May;10(2):217-26
18853206
J Clin Epidemiol. 1992 Jun;45(6):613-9
1607900
Eur Respir J. 2009 Oct;34(4):850-7
19357148
Can Respir J. 2008 Jan-Feb;15(1):13-9
18292848
Ann Epidemiol. 2000 Oct 1;10(7):480
11018428
J Gen Intern Med. 2007 Dec;22 Suppl 3:403-7
18026809
Pol Merkur Lekarski. 2009 Mar;26(153):208-14
19388534
J Ambul Care Manage. 2004 Jul-Sep;27(3):249-62
15287215
Respirology. 2003 Dec;8(4):504-8
14629656
Respir Med. 2009 May;103(5):714-21
19168340
Respir Med. 2003 Mar;97 Suppl C:S43-50
12647942
Respir Med. 2003 Mar;97 Suppl C:S33-42
12647941